← Back to Search

Diagnostic Test

Lung Ultrasound for Lung Transplant

N/A
Recruiting
Led By Tathagat Narula, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 0 to month 12
Awards & highlights

Study Summary

This trial is testing a new, non-invasive way to diagnose lung rejection and infection.

Who is the study for?
This trial is for adults over 18 who have had a lung or heart-lung transplant. They must be symptom-free, with clear chest X-rays and normal breathing test results (FEV1) that haven't dropped more than 10% from their usual. People can't join if they can't consent or have conditions like subcutaneous emphysema that make it hard to get good ultrasound images.Check my eligibility
What is being tested?
The study is testing the use of lung ultrasounds as a non-invasive method to detect lung rejection and infection in patients who've received lung transplants. It aims to find safer ways to diagnose these serious complications without invasive procedures.See study design
What are the potential side effects?
Since the intervention involves only lung ultrasound, which is non-invasive, there are typically no side effects associated with this procedure.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 0 to month 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 0 to month 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Establish predictive value of lung ultrasound

Trial Design

1Treatment groups
Experimental Treatment
Group I: Receiving UltrasoundExperimental Treatment1 Intervention
Every patient will receive a lung ultrasound prior to each scheduled bronchoscopy until the study stops.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Lung ultrasound
2021
N/A
~2160

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,234 Previous Clinical Trials
3,771,759 Total Patients Enrolled
3 Trials studying Bronchiectasis
115 Patients Enrolled for Bronchiectasis
Tathagat Narula, MDPrincipal Investigator - Mayo Clinic
Mayo Clinic Hospital Jacksonville

Media Library

Lung ultrasound (Diagnostic Test) Clinical Trial Eligibility Overview. Trial Name: NCT04582279 — N/A
Bronchiectasis Research Study Groups: Receiving Ultrasound
Bronchiectasis Clinical Trial 2023: Lung ultrasound Highlights & Side Effects. Trial Name: NCT04582279 — N/A
Lung ultrasound (Diagnostic Test) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04582279 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment process for this trial still open to applicants?

"Affirmative. According to the information found on clinicaltrials.gov, this clinical study is currently seeking participants for enrollment. The trial was established on October 28th 2020 and most recently edited on June 9th 2022 with a target recruitment of 90 individuals from one location."

Answered by AI

What is the current capacity for participants in this clinical investigation?

"Affirmative, the information available on clinicaltrials.gov confirms that this medical research is actively accepting candidates. The study was initially launched on October 28th 2020 and has been updated as recently as June 9th 2022 with a goal of recruiting 90 patients from 1 site."

Answered by AI

Who else is applying?

What state do they live in?
Louisiana
How old are they?
65+
What site did they apply to?
Mayo Clinic in Florida
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
Lung Ultrasound Artefact Analysis for Exclusion of Acute Rejection in Lung Transplant Recipients
Tathagat Narula 2020. "Lung Ultrasound Artefact Analysis for Exclusion of Acute Rejection in Lung Transplant Recipients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04582279.
All > Bronchiectasis
~18 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top